Article
Performance assessment of the Illumina massively parallel sequencing platform for deep sequencing analysis of viral minority variants.
Journal of virological methods - 1 Sept 2015
Thys Kim, Verhasselt Peter, Reumers Joke, Verbist Bie M P, Maes Bart, Aerssens Jeroen
Abstract excerpt
Massively parallel sequencing (MPS) technology has opened new avenues to study viral dynamics and treatment-induced resistance mechanisms of infections such as human immunodeficiency virus (HIV) and hepatitis C virus (HCV). Whereas the Roche/454 platform has been used widely for the detection of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
